FDA Announces New Date for Webinar on Genome Editing in Animals

On April 25, 2019, the U.S. Food and Drug Administration’s (FDA) Center for Veterinary Medicine (CVM), with participation from the FDA’s Center for Biologics Evaluation and Research (CBER), will hold a public webinar about genome editing in animals, an innovative and rapidly evolving technology that offers significant public health benefits.While the webinar is open to the public, the content will be focused on information for those using genome editing to develop animals with genomic alterations.The webinar will focus primarily on current scientific evidence, promising uses of this technology in animals, and the potential risks. It will also provide information about CVM’s flexible, risk-based approach to the regulation of intentional genomic alterations (IGAs) in animals, including alterations made with genome editing, and how, if needed, to navigate FDA approval requirements for IGAs that are products of this technology. It will also seek to address common questions associated with FDA oversight. The final portion of the webinar will be dedicated to answering stakeholder-submitted questions.